Mouse models of diisocyanate asthma

American Journal of Respiratory Cell and Molecular Biology

Volumn 27, Issue 4, 2002, Pages 385-390

  Redlich, Carrie A ^a   Wisnewski, Adam V ^a   Gordon, Terry ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA;

EID: 0036789511     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.F249     Document Type: Review

References (64)

1. NIOSH. 1996. Preventing asthma and death from diisocyanate exposure. Public Health Service, CDC/NIOSH Alert 96-111.
2. Matheson, J. M., R. Lemus, R. W. Lange, M. H. Karol, and M. I. Luster. 2002. Role of tumor necrosis factor in toluene diisocyanate asthma. Am. J. Respir. Cell Mol. Biol. 27:396-405.
3. Kimber, I. 1996. The role of the skin in the development of chemical respiratory hypersensitivity. Toxicol. Lett. 86;2-3:89-92.
4. Petsonk, E. L., M. L. Wang, D. M. Lewis, P. D. Siegel, and B. J. Husberg. 2000. Asthma-like symptoms in wood product plant workers exposed to methylene diphenyl diisocyanate. Chest 118:1183-1193.
5. Streicher, R. P., C. M. Reh, R. Key-Schwartz, P. C. Schlecht, M. E. Cassinelli, and P. F. O'Connor. 2002. Selecting isocyanate sampling and analytical methods. Appl. Occup. Environ. Hyg. 17:157-162.
6. Tarlo, S. M., D. Banks, G. Liss, and I. Broder. 1997. Outcome determinants for isocyanate induced occupational asthma among compensation claimants. Occup. Environ. Med. 54:756-761.
7. Park, H. S., and D. H. Nahm. 1997. Prognostic factors for toluene diisocyanate-induced occupational asthma after removal from exposure. Clin. Exp. Allergy 27:1145-1150.
8. Redlich, C. A., and M. H. Karol. 2002. Diisocyanate asthma: clinical aspects and immunopathogenesis. Int. Immunopharmacol. 2;2-3:213-224.
9. Bernstein, J. A. 1996. Overview of diisocyanate occupational asthma. Toxicology 111;1-3:181-189.
10. Mapp, C. E., B. Beghe, A. Balboni, G. Zamorani, M. Padoan, L. Jovine, O. R. Baricordi, and L. M. Fabbri. 2000. Association between HLA genes and susceptibility to toluene diisocyanate-induced asthma. Clin. Exp. Allergy 30:651-656.
11. Piirila, P., H. Wikman, R. Luukkonen, K. Kaaria, C. Rosenberg, H. Nordman, H. Norppa, H. Vainio, and A. Hirvonen. 2001. Glutathione S-transferase genotypes and allergic responses to diisocyanate exposure. Pharmacogenetics 11:437-445.
12. Rihs, H. P., T. Barbalho-Krolls, H. Huber, and X. Baur. 1997. No evidence for the influence of HLA class II in alleles in isocyanate-induced asthma. Am. J. Ind. Med. 32:522-527.
13. Hendrick, D. J. 2002. Diagnostic tests for occupational asthma. Am. J. Respir. Crit. Care Med. 166:436-437.
14. Bernstein, D. I., and A. Jolly. 1999. Current diagnostic methods for diisocyanate induced occupational asthma. Am. J. Ind. Med. 36:459-468.
15. Vasudev, S. C., T. Chandy, and C. P. Sharma. 2000. The anticalcification effect of polyethylene glycol-immobilized on hexamethylene diisocyanate treated pericardium. Artif. Cells Blood Substit. Immobil. Biotechnol. 28:79-94.
16. Bernstein, D. I., A. Cartier, J. Cote, J. L. Malo, L. P. Boulet, M. Wanner, J. Milot, J. L'Archeveque, C. Trudeau, and Z. Lummus. 2002. Diisocyanate antigen-stimulated monocyte chemoattractant protein-1 synthesis has greater test efficiency than specific antibodies for identification of diisocyanate asthma. Am. J. Respir. Crit. Care Med. 166:445-450.
17. Cullinan, P. 1998. Occupational asthma, IgE and IgG. Clin. Exp. Allergy 28:668-670.
18. Tarlo, S. M. 1999. Diisocyanate sensitization and antibody production. J. Allergy Clin. Immunol. 103:739-741. (published erratum appears in J. Allergy Clin. Immunol. 1999;104;5:1083.)
19. Bernstein, J. A., J. Munson, Z. L. Lummus, K. Balakrishnan, and G. Leikauf. 1997. T cell receptor V beta gene segment expression in diisocyanate-induced occupational asthma. J. Allergy Clin. Immunol. 99:245-250.
20. Lummus, Z. L., R. Alam, J. A. Bernstein, and D. I. Bernstein. 1998. Diisocyanate antigen-enhanced production of monocyte chemoattractant protein-1, IL-8, and tumor necrosis factor-alpha by peripheral mononuclear cells of workers with occupational asthma. J. Allergy Clin. Immunol. 102:265-274.
21. Redlich, C. A., M. H. Stowe, A. V. Wisnewski, E. A. Eisen, M. H. Karol, R. Lemus, C. T. Holm, J. S. Chung, J. Sparer, Y. Liu, S. R. Woskie, J. Appiah-Pippim, R. Gore, and M. R. Cullen. 2001. Subclinical immunologic and physiologic responses in hexamethylene diisocyanate-exposed auto body shop workers. Am. J. Ind. Med. 39:587-597.
22. Sood, A., and C. A. Redlich. 2001. Pulmonary function tests at work. Clin. Chest Med. 22:783-793.
23. Wisnewski, A. V., R. Srivastava, C. Herick, L. Xu, R. Lemus, H. Cain, N. M. Magoski, M. H. Karol, K. Bottomly, and C. A. Redlich. 2000. Identification of human lung and skin proteins conjugated with hexamethylene diisocyanate in vitro and in vivo. Am. J. Respir. Crit. Care Med. 162:2330-2336.
24. Wisnewski, A. V., R. Lemus, M. H. Karol, and C. A. Redlich. 1999. Isocyanate-conjugated human lung epithelial cell proteins: a link between exposure and asthma? J. Allergy Clin. Immunol. 104:341-347.
25. Jin R., B. W. Day, and M. H. Karol. 1993. Toluene diisocyanate protein adducts in the bronchoalveolar lavage of guinea pigs exposed to vapors of the chemical. Chem. Res. Toxicol. 6:906-912.
26. Sepai, O., D. Henschler, and G. Sabbioni. 1995. Albumin adducts, hemoglobin adducts and urinary metabolites in workers exposed to 4,4′-methylenediphenyl diisocyanate. Carcinogenesis 16:2583-2587.
27. Lange, R. W., B. W. Day, R. Lemus, V. A. Tyurin, V. E. Kagan, and M. H. Karol. 1999. Intracellular S-glutathionyl adducts in murine lung and human bronchoepithelial cells after exposure to diisocyanatotoluene. Chem. Res. Toxicol. 12:931-936.
28. Lange, R. W., R. C. Lantz, D. B. Stolz, S. C. Watkins, P. Sundareshan, R. Lemus, and M. H. Karol. 1999. Toluene diisocyanate colocalizes with tubulin on cilia of differentiated human airway epithelial cells. Toxicol. Sci. 50:64-71.
29. Wisnewski, A. V., and C. A. Redlich. 2001. Recent developments in diisocyanate asthma. Curr. Opin. Allergy Clin. Immunol. 1:169-175.
30. Mapp, C., P. Boschetto, D. Miotto, E. De Rosa, and L. M. Fabbri. 1999. Mechanisms of occupational asthma. Ann. Allergy Asthma Immunol. 83:645-664.
31. Maestrelli, P., P. Occari, G. Turato, S. A. Papiris, A. Di Stefano, C. E. Mapp, G. F. Milani, L. M. Fabbri, and M. Saetta. 1997. Expression of interleukin (IL)-4 and IL-5 proteins in asthma induced by toluene diisocyanate (TDI). Clin. Exp. Allergy 27:1292-1298.
32. Finotto, S., L. M. Fabbri, V. Rado, C. E. Mapp, and P. Maestrelli. 1991. Increase in numbers of CD8 positive lymphocytes and eosinophils in peripheral blood of subjects with late asthmatic reactions induced by toluene diisocyanate. Br. J. Ind. Med. 48:116-121.
33. Lee, M., S. Park, H. S. Park, and J. K. Youn. 1998. Cytokine secretion patterns of T cells responding to haptenized-human serum albumin in toluene diisocyanate (TDI)-induced asthma patients. J. Korean Med. Sci. 13:459-465.
34. Maestrelli, P., G. F. Del Prete, M. De Carli, M. M. D'Elios, M. Saetta, A. Di Stefano, C. E. Mapp, S. Romagnani, and L. M. Fabbri. 1994. CD8 T cell clones producing interleukin-5 and interferon-gamma in bronchial mucosa of patients with asthma induced by toluene diisocyanate. Scand. J. Work Environ. Health 20:376-381.
35. Tee, R. D., P. Cullinan, J. Welch, P. S. Burge, and A. J. Newman-Taylor. 1998. Specific IgE to isocyanates: a useful diagnostic role in occupational asthma. J. Allergy Clin. Immunol. 101:709-715.
36. Gelfand, E. W. 2002. Pro: mice are a good model of human airway disease. Am. J. Respir. Crit. Care Med. 166;1:5-6.
37. Karol, M. H., J. Stadler, and C. Magreni. 1985. Immunotoxicologic evaluation of the respiratory system: animal models for immediate- and delayed-onset pulmonary hypersensitivity. Fundam. Appl. Toxicol. 5:459-472.
38. Mapp, C. E., J. R. Lapa e Silva, R. E. Lucchini, P. Chitano, V. Rado, M. Saetta, M. Pretolani, M. H. Karol, P. Maestrelli, and L. M. Fabbri. 1996. Inflammatory events in the blood and airways of guinea pigs immunized to toluene diisocyanate. Am. J. Respir. Crit. Care Med. 154:201-208.
39. Mapp, C. E., R. E. Lucchini, D. Miotto, P. Chitano, L. Jovine, M. Saetta, P. Maestrelli, D. R. Springall, J. Polak, and L. M. Fabbri. 1998. Immunization and challenge with toluene diisocyanate decrease tachykinin and calcitonin gene-related peptide immunoreactivity in guinea pig central airways. Am. J. Respir. Crit. Care Med. 158:263-269.
40. Niimi, A., R. Amitani, K. Yamada, K. Tanaka, and F. Kuze. 1996. Late respiratory response and associated eosinophilic inflammation induced by repeated exposure to toluene diisocyanate in guinea pigs. J. Allergy Clin. Immunol. 97:1308-1319.
41. Pauluhn, J., P. Eidmann, and U. Mohr. 2002. Respiratory hypersensitivity in guinea pigs sensitized to 1,6-hexamethylene diisocyanate (HDI): comparison of results obtained with the monomer and homopolymers of HDI. Toxicology 171;2-3:147-160.
42. Pauluhn, J., and U. Mohr. 2001. Inhalation toxicity of 1,6-hexamethylene diisocyanate homopolymers (HDI-IC and HDI-BT): results of subacute and subchronic repeated inhalation exposure studies. Inhal. Toxicol. 13:513-532.
43. Gordon, T., D. Sheppard, D. M. McDonald, S. Distefano, and L. Scypinski. 1985. Airway hyperresponsiveness and inflammation induced by toluene diisocyanate in guinea pigs. Am. Rev. Respir. Dis. 132:1106-1112.
44. Gordon, T., and D. Sheppard. 1988. Tumor necrosis factor inhibits a polymorphonuclear leukocyte-dependent airway edema in guinea pigs. J. Appl. Physiol. 64:1688-1692.
45. Karol, M. H. 1991. Comparison of clinical and experimental data from an animal model of pulmonary immunologic sensitivity. Ann. Allergy 66:485-489.
46. Ebino, K., H. Ueda, H. Kawakatsu, Y. Shutoh, T. Kosaka, E. Nagayoshi, R. Lemus, and M. H. Karol. 2001. Isolated airway exposure to toluene diisocyanate results in skin sensitization. Toxicol. Lett. 121:79-85.
47. Dearman, R. J., L. M. Spence, and I. Kimber. 1992. Characterization of murine immune responses to allergenic diisocyanates. Toxicol. Appl. Pharmacol. 112:190-197.
48. Dearman, R. J., A. Moussavi, D. M. Kemeny, and I. Kimber. 1996. Contribution of CD4+ and CD8+ T lymphocyte subsets to the cytokine secretion patterns induced in mice during sensitization to contact and respiratory chemical allergens. Immunology 89:502-510.
49. Tse, C. S., S. E. Chen, and I. L. Bernstein. 1979. Induction of murine reaginic antibodies by toluene diisocyanate: an animal model of immediate hypersensitivity reactions to isocyanates. Am. Rev. Respir. Dis. 120:829-835.
50. Thorne, P. S., J. A. Hillebrand, G. R. Lewis, and M. H. Karol. 1987. Contact sensitivity by diisocyanates: potencies and cross-reactivities. Toxicol. Appl. Pharmacol. 87:155-165.
51. Herrick, C. A., L. Xu, A. V. Wisnewski, J. Das, C. A. Redlich, and K. Bottomly. 2002. A novel mouse model of diisocyanate-induced asthma showing allergic-type inflammation in the lung after inhaled antigen challenge. J. Allergy Clin. Immunol. 109:873-878.
52. Lee, Y. C., C. H. Song, H. B. Lee, J. L. Oh, Y. K. Rhee, H. S. Park, and G. Y. Koh. 2001. A murine model of toluene diisocyanate-induced asthma can be treated with matrix metalloproteinase inhibitor. J. Allergy Clin. Immunol. 108:1021-1026.
53. Lee, Y. C., Y. G. Kwak, and C. H. Song. 2002. Contribution of vascular endothelial growth factor to airway hyperresponsiveness and inflammation in a murine model of toluene diisocyanate-induced asthma. J. Immunol. 168:3595-3600.
54. Matheson, J. M., R. W. Lange, R. Lemus, M. H. Karol, and M. I. Luster. 2001. Importance of inflammatory and immune components in a mouse model of airway reactivity to toluene diisocyanate (TDI). Clin. Exp. Allergy 31:1067-1076.
55. Scheerens, H., T. L. Buckley, E. M. Davidse, J. Garssen, F. P. Nijkamp, and H. Van Loveren. 1996. Toluene diisocyanate-induced in vitro tracheal hyperreactivity in the mouse. Am. J. Respir. Crit. Care Med. 154:858-865.
56. Scheerens, H., T. L. Buckley, T. Muis, H. Van Loveren, and F. P. Nijkamp. 1996. The involvement of sensory neuropeptides in toluene diisocyanate-induced tracheal hyperreactivity in the mouse airways. Br. J. Pharmacol. 119:1665-1671.
57. Scheerens, H., T. L. Buckley, T. L. Muis, J. Garssen, J. Dormans, F. P. Nijkamp, and H. Van Loveren. 1999. Long-term topical exposure to toluene diisocyanate in mice leads to antibody production and in vivo airway hyperresponsiveness three hours after intranasal challenge. Am. J. Respir. Crit. Care Med. 159:1074-1080.
58. de Benedictis, F. M., M. M. del Giudice, S. Severini, and F. Bonifazi. 2001. Rhinitis, sinusitis and asthma: one linked airway disease. Paediatr. Respir. Rev. 2:358-364.
59. Passalacqua, G., G. Ciprandi, and G. W. Canonica. 2001. The nose-lung interaction in allergic rhinitis and asthma: united airways disease. Curr Opin Allergy Clin Immunol 1:7-13.
60. Vinuya, R. Z. 2002. Upper airway disorders and asthma: a syndrome of airway inflammation. Ann. Allergy. Asthma Immunol. 88(4 Suppl 1):8-15.
61. Redlich, C. A., M. H. Stowe, B. A. Coren, A. V. Wisnewski, C. T. Holm, and M. R. Cullen. 2002. Diisocyanate-exposed autobody shop workers: a one year follow-up. Am. J. Ind. Med. (in press)
62. Redlich, C. A., M. H. Karol, C. Graham, R. J. Homer, C. T. Holm, J. A. Wirth, and M. R. Cullen. 1997. Airway isocyanate-adducts in asthma induced by exposure to hexamethylene diisocyanate. Scand. J. Work Environ. Health 23:227-231.
63. Persson, C. G. 2002. Con: mice are not a good model of human airway disease. Am. J. Respir. Crit. Care. Med. 166;1:6-7.
64. Kumar, R. K., and P. S. Foster. 2002. Modeling allergic asthma in mice: pitfalls and opportunities. Am. J. Respir. Cell Mol. Biol. 27:267-272.